MedPath

Whey Protein Supplementation in High School Athletes

Not Applicable
Completed
Conditions
Body Weight Changes
Athletic Performance
Recovery
Sleep
Interventions
Dietary Supplement: Carbohydrate Placebo Control
Dietary Supplement: Whey Protein Supplement
Registration Number
NCT05589129
Lead Sponsor
University of Utah
Brief Summary

The overall aim of this project is to compare protein supplementation on performance, recovery, and body composition changes in adolescent soccer players between the whey protein and the control group in response to the 10-12-week intervention.

Detailed Description

Informed Consent, Parental Permission and Assent: These will be obtained over Zoom, prior to participation in any study procedures.

Randomization: Randomization will occur following baseline testing. Participants will be randomized via random number generator stratified by sex, into either the whey protein supplement group or the placebo (isocaloric) control group.

Baseline and Post-Intervention testing will occur over a single day for each participant.

Baseline:

All athletes will report to testing facilities for a single blood draw to measure inflammatory biomarkers and a body composition assessment (via BodPod) to measure fat mass and fat free mass. Participants will then be escorted to a track where they will run a 30-yard dash to assess their speed and a 1.5-mile run to assess their estimated maximal rate of oxygen consumption (VO2max). Participants will then be transferred back to the testing facility where they will undergo assessment of lower body muscle fatigue (via HumacNorm).

Questionnaires: Athletes will complete the Munich Chronotype Questionnaire and the Pittsburg Sleep Quality Index (PSQI). Participants will also complete 3-day, 24-hour dietary recalls (via ASA-24).

Sleep measures: Fitbit (Inspire 2) will be used measure sleep efficiency, duration, and staging. Fitabase will be utilized to receive Fitbit data. Participants will be instructed to wear their Fitbit for 1-week.

Intervention:

In-season soccer practices and competition will occur 6-days per week across a 10-12 week period, depending on how far teams advance in postseason play. During the 10-12-weeks, participants will consume their assigned supplement or placebo twice per day, every day, immediately after practice or competition (or midday on rest days), and \~1 hour before bedtime.

Sleep measures: Sleep measures will be evaluated as described above. Sleep measures will be collected at weeks 2, 4, 6, 8, and 10.

Questionnaires: Participants will complete 3-days of 24-hour dietary recalls (via ASA-24) at weeks 5 and 10. Pittsburg Sleep Quality Index (PSQI), a delayed-onset muscle soreness questionnaire and a GI symptom Questionnaire will be completed at weeks 2, 4, 6, 8 and 10.

Urine Samples: We will randomly assign participants to provide urine samples at weeks 4 and 7 as a sham measure of compliance to supplementation protocol.

Post-testing will be the same as pre-testing and will commence after the 10-12-week competitive season. All measures described above in baseline testing will be repeated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • 13-18 years old; male and female High school soccer players
Exclusion Criteria
  • non-adolescents; untreated or underlying metabolic or cardiovascular diseases; allergies to dairy, or any allergies ingredients in the study provided granola bar or bagels, such as soy, wheat, tree nuts, peanuts, milk, and sesame.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Carbohydrate ControlCarbohydrate Placebo ControlCarbohydrate control will come in powder form and will consist of 20g of carbohydrate and 21.6g of product. We will use Nesquick Chocolate Powder mix.
Whey Protein SupplementWhey Protein SupplementWhey protein will come in powder form and will consist of 20g of protein, and 25.3g of product. We will use Optimum Nutrition Double Chocolate Whey Protein Isolate.
Primary Outcome Measures
NameTimeMethod
Changes in Fat MassMeasured at baseline and post-intervention (10-12-weeks)

Measured via BodPod

Changes in Fat Free MassMeasured at baseline and post-intervention (10-12-weeks)

Measured via BodPod

Secondary Outcome Measures
NameTimeMethod
Sleep EfficiencyMeasured at baseline, 2-, 4-, 6-, 8-weeks and post-intervention (10-12-weeks)

Measured via Fitbit devices. Sleep efficiency is measured based on how long and individual is asleep over the time spent in bed during the night.

Changes in SpeedMeasured at baseline and post-intervention (10-12-weeks)

30 yard sprint

Sleep StagingMeasured at baseline, 2-, 4-, 6-, 8-weeks and post-intervention (10-12-weeks)

Measured via Fitbit devices. Sleep stages are different periods of sleep where muscle tone and heart rate vary.

Estimated Cardiorespiratory Fitness (V02max)Measured at baseline and post-intervention (10-12-weeks)

Measured via 1.5-mile run time

Changes in Muscular FatigueMeasured at baseline and post-intervention (10-12-weeks)

Measured via leg extension machine (HumacNorm) using isometric muscle contraction in the quadriceps muscle.

Sleep DurationMeasured at baseline, 2-, 4-, 6-, 8-weeks and post-intervention (10-12-weeks)

Measured via Fitbit devices. Sleep duration is measured based on how long the individual is asleep.

Trial Locations

Locations (1)

Grace Zimmerman

đŸ‡ºđŸ‡¸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath